You need to enable JavaScript to run this app.
FDA relaxes oversight of general wellness devices, CDS software
Regulatory News
Ferdous Al-Faruque
Artificial intelligence/machine learning (AI/ML)
Diagnostics/IVDs
Digital health/SaMD/AI
Guidance
Medical Devices
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)